Anticorps Recombinant de lapin anti-OLIG2

OLIG2 Recombinant Antibody for WB, IF-P, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

240839C1

N° de cat : 82806-7-PBS

Synonymes

240839C1, 5O7, bHLHb1, bHLHe19, Class B basic helix-loop-helix protein 1



Informations sur le produit

82806-7-PBS cible OLIG2 dans les applications de WB, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène OLIG2 Protéine recombinante Ag5089
Nom complet oligodendrocyte lineage transcription factor 2
Masse moléculaire calculée 32 kDa
Poids moléculaire observé35 kDa
Numéro d’acquisition GenBankBC047511
Symbole du gène OLIG2
Identification du gène (NCBI) 10215
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

OLIG2, also named as BHLHB1, BHLHE19, PRKCBP2 and RACK17, is required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Cooperates with OLIG1, OLIG2 establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development. OLIG2 is widely expressed in subsets of glia cells and progenitors, and it is strongly induced at different sites by both acute and chronic injury, albeit with different mechanisms. OLIG2 acts as a repressor of neurogenesis in cells reacting to brain injury. It may represent an effective approach towards evoking neuronal repair from parenchymal precursors.(PMID:19390819 )

{{ptg:RelatedPrimaryAntibodies}}